Thienopyridone derivatives as kinase inhibitors

Details for Australian Patent Application No. 2004249495 (hide)

Owner Celltech R & D Limited

Inventors Davis, Jeremy Martin; Brookings, Daniel Christopher; Langham, Barry John

Agent Watermark

Pub. Number AU-A-2004249495

PCT Pub. Number WO2004/113347

Priority 0329485.7 19.12.03 GB; 0314492.0 20.06.03 GB

Filing date 18 June 2004

Wipo publication date 29 December 2004

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113347 Priority application(s): WO2004/113347

14 February 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249496-Hydroxamate sulfonamides as CD23 shedding inhibitors

2004249494-2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders